Patient similarity network of newly diagnosed multiple myeloma identifies patient subgroups with distinct genetic features and clinical implications
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Patient similarity network of newly diagnosed multiple myeloma identifies patient subgroups with distinct genetic features and clinical implications
Authors
Keywords
-
Journal
Science Advances
Volume 7, Issue 47, Pages -
Publisher
American Association for the Advancement of Science (AAAS)
Online
2021-11-18
DOI
10.1126/sciadv.abg9551
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma
- (2021) Mehmet Kemal Samur et al. Nature Communications
- Integrative pathway enrichment analysis of multivariate omics data
- (2020) Marta Paczkowska et al. Nature Communications
- MAGE-A inhibit apoptosis and promote proliferation in multiple myeloma through regulation of BIM and p21Cip1
- (2020) Anna Huo-Chang Mei et al. Oncotarget
- Multiple myeloma: 2020 update on diagnosis, risk‐stratification and management
- (2020) S. Vincent Rajkumar AMERICAN JOURNAL OF HEMATOLOGY
- Oncolytic measles virus therapy enhances tumor antigen-specific T-cell responses in patients with multiple myeloma
- (2020) Nandakumar Packiriswamy et al. LEUKEMIA
- Dual targeting of BCL2 and MCL1 rescues myeloma cells resistant to BCL2 and MCL1 inhibitors associated with the formation of BAX/BAK hetero-complexes
- (2020) Carolane Seiller et al. Cell Death & Disease
- Timing the initiation of multiple myeloma
- (2020) Even H. Rustad et al. Nature Communications
- Transmembrane Activator and CAML Interactor (TACI): Another Potential Target for Immunotherapy of Multiple Myeloma?
- (2020) Shengli Xu et al. Cancers
- Genome-Wide Somatic Alterations in Multiple Myeloma Reveal a Superior Outcome Group
- (2020) Mehmet Kemal Samur et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical characteristics and treatment outcomes of newly diagnosed multiple myeloma with chromosome 1q abnormalities
- (2020) Nadine Abdallah et al. Blood Advances
- The FMS like Tyrosine Kinase 3 (FLT3) Is Overexpressed in a Subgroup of Multiple Myeloma Patients with Inferior Prognosis
- (2020) Normann Steiner et al. Cancers
- Next-generation characterization of the Cancer Cell Line Encyclopedia
- (2019) Mahmoud Ghandi et al. NATURE
- Preclinical evaluation of the simultaneous inhibition of MCL-1 and BCL-2 with the combination of S63845 and venetoclax in multiple myeloma
- (2019) Esperanza M Algarín et al. HAEMATOLOGICA
- Relapsed refractory multiple myeloma: a comprehensive overview
- (2019) Abdul Hamid Bazarbachi et al. LEUKEMIA
- An acquired high-risk chromosome instability phenotype in multiple myeloma: Jumping 1q Syndrome
- (2019) Jeffrey R. Sawyer et al. Blood Cancer Journal
- Recent advance in the development of novel, selective and potent FGFR inhibitors
- (2019) Feng-Tao Liu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Genomic landscape and chronological reconstruction of driver events in multiple myeloma
- (2019) Francesco Maura et al. Nature Communications
- Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone
- (2019) Timothy M. Schmidt et al. Blood Cancer Journal
- Daratumumab in high‐risk relapsed/refractory multiple myeloma patients: adverse effect of chromosome 1q21 gain/amplification and GEP70 status on outcome
- (2019) Meera Mohan et al. BRITISH JOURNAL OF HAEMATOLOGY
- Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma
- (2018) Brian A. Walker et al. BLOOD
- MAGE-A antigens as targets for cancer immunotherapy
- (2018) Erik Schooten et al. CANCER TREATMENT REVIEWS
- Patient Similarity Networks for Precision Medicine
- (2018) Shraddha Pai et al. JOURNAL OF MOLECULAR BIOLOGY
- Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups
- (2018) Niccolo Bolli et al. LEUKEMIA
- Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis
- (2018) Sean P. Pitroda et al. Nature Communications
- Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myeloma
- (2017) A Laganà et al. LEUKEMIA
- Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients
- (2017) V Shah et al. LEUKEMIA
- Computational correction of copy number effect improves specificity of CRISPR–Cas9 essentiality screens in cancer cells
- (2017) Robin M Meyers et al. NATURE GENETICS
- CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer
- (2017) Malachi Griffith et al. NATURE GENETICS
- Multiple myeloma
- (2017) Shaji K. Kumar et al. Nature Reviews Disease Primers
- Expression Profile of BCL-2, BCL-XL, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models
- (2016) E. A. Punnoose et al. MOLECULAR CANCER THERAPEUTICS
- A novel small molecule agent displays potent anti-myeloma activity by inhibiting the JAK2-STAT3 signaling pathway
- (2016) Zubin Zhang et al. Oncotarget
- Smoldering multiple myeloma
- (2015) S. V. Rajkumar et al. BLOOD
- Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
- (2015) Antonio Palumbo et al. JOURNAL OF CLINICAL ONCOLOGY
- Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma
- (2015) Brian A. Walker et al. JOURNAL OF CLINICAL ONCOLOGY
- The Molecular Signatures Database Hallmark Gene Set Collection
- (2015) Arthur Liberzon et al. Cell Systems
- Jumping translocations of 1q12 in multiple myeloma: a novel mechanism for deletion of 17p in cytogenetically defined high-risk disease
- (2014) J. R. Sawyer et al. BLOOD
- Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy
- (2014) Jens G. Lohr et al. CANCER CELL
- Similarity network fusion for aggregating data types on a genomic scale
- (2014) Bo Wang et al. NATURE METHODS
- Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
- (2014) Niccolo Bolli et al. Nature Communications
- IMWG consensus on risk stratification in multiple myeloma
- (2013) W J Chng et al. LEUKEMIA
- Breast Tumors with Elevated Expression of 1q Candidate Genes Confer Poor Clinical Outcome and Sensitivity to Ras/PI3K Inhibition
- (2013) Muthulakshmi Muthuswami et al. PLoS One
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
- (2012) Wanjuan Yang et al. NUCLEIC ACIDS RESEARCH
- Integrative Subtype Discovery in Glioblastoma Using iCluster
- (2012) Ronglai Shen et al. PLoS One
- Molecular signatures database (MSigDB) 3.0
- (2011) A. Liberzon et al. BIOINFORMATICS
- Chromosome 1q21 amplification and oncogenes in hepatocellular carcinoma
- (2010) Leilei Chen et al. ACTA PHARMACOLOGICA SINICA
- A mechanistic rationale for MEK inhibitor therapy in myeloma based on blockade of MAF oncogene expression
- (2010) C. M. Annunziata et al. BLOOD
- Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients
- (2010) A. Broyl et al. BLOOD
- Jumping translocations of the long arms of chromosome 1 in myeloid malignancies is associated with a high risk of transformation to acute myeloid leukaemia*
- (2010) Vesna Najfeld et al. BRITISH JOURNAL OF HAEMATOLOGY
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
- (2009) M. D. Robinson et al. BIOINFORMATICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started